scispace - formally typeset
Search or ask a question
JournalISSN: 0724-4983

World Journal of Urology 

Springer Science+Business Media
About: World Journal of Urology is an academic journal published by Springer Science+Business Media. The journal publishes majorly in the area(s): Medicine & Prostate cancer. It has an ISSN identifier of 0724-4983. Over the lifetime, 5661 publications have been published receiving 122388 citations.


Papers
More filters
Journal ArticleDOI
TL;DR: The NOBLE studies do not support the commonly held notion that women are considerably more likely than men to have urgency-related bladder control problems, and overactive bladder, with and without urge incontinence, has a clinically significant impact on quality-of-life, quality- of-sleep, and mental health, in both men and women.
Abstract: Context: the National Overactive BLadder Evaluation (NOBLE) Program was initiated to better understand the prevalence and burden of overactive bladder in a broad spectrum of the United States population. Objective: to estimate the prevalence of overactive bladder with and without urge incontinence in the US, assess variation in prevalence by sex and other factors, and measure individual burden. Design: US national telephone survey using a clinically validated interview and a follow-up nested study comparing overactive bladder cases to sex- and age-matched controls. Setting: noninstitutionalized US adult population. Participants: a sample of 5,204 adults ≥18 years of age and representative of the US population by sex, age, and geographical region. Main outcome measures: prevalence of overactive bladder with and without urge incontinence and risk factors for overactive bladder in the US. In the nested case-control study, SF-36, CES-D, and MOS sleep scores were used to assess impact. Results: the overall prevalence of overactive bladder was similar between men (16.0%) and women (16.9%), but sex-specific prevalence differed substantially by severity of symptoms. In women, prevalence of urge incontinence increased with age from 2.0% to 19% with a marked increase after 44 years of age, and in men, increased with age from 0.3% to 8.9% with a marked increase after 64 years of age. Across all age groups, overactive bladder without urge incontinence was more common in men than in women. Overactive bladder with and without urge incontinence was associated with clinically and significantly lower SF-36 quality-of-life scores, higher CES-D depression scores, and poorer quality of sleep than matched controls. Conclusions: the NOBLE studies do not support the commonly held notion that women are considerably more likely than men to have urgency-related bladder control problems. The overall prevalence of overactive bladder does not differ by sex; however, the severity and nature of symptom expression does differ. Sex-specific anatomic differences may increase the probability that overactive bladder is expressed as urge incontinence among women compared with men. Nonetheless, overactive bladder, with and without incontinence, has a clinically significant impact on quality-of-life, quality-of-sleep, and mental health, in both men and women.

2,017 citations

Journal ArticleDOI
TL;DR: The burden of UBC will increase in less developed areas of the world, and changes can be attributed to global changes in exposure to risk factors for UBC and growth and aging of the World population.
Abstract: Urinary bladder cancer (UBC) is a common disease worldwide. At any point in time 2.7 million people have a history of UBC. The incidence of UBC varies over the world with highest rates in developed communities. But the burden of UBC will increase in less developed areas of the world. These changes can be attributed to global changes in exposure to risk factors for UBC and growth and aging of the world population.

824 citations

Journal ArticleDOI
TL;DR: The literature on modifiable risk factors has continued to expand rapidly, and diet and lifestyle risk factors—focusing in particular on exercise and smoking cessation—as important determinants of both prostate cancer specific and overall health outcomes are reviewed.
Abstract: than in most western countries. The literature on modifiable risk factors has continued to expand rapidly. Peisch et al. (10.1007/s00345-016-1914-3) review diet and lifestyle risk factors—focusing in particular on exercise and smoking cessation—as important determinants of both prostate cancer specific and overall health outcomes. Stopsack et al. (10.1007/s00345-016-1912-5) critique the literature on the effects of metformin, statins, and other medications on prostate cancer risk, and Albanes et al. (10.1007/ s00345-016-1878-3) provide a deep dive into the impacts of vitamins and other micronutrients. Finally, Nordström et al. (10.1007/s00345-016-1907-2) offer a commentary on one possible evolution in prostate cancer screening policy, based on the innovative STHLM-3 trial. We hope these articles will be of great interest to the Journal’s readership, and will help stimulate the next generation of research into the genetic and environmental determinants of prostate cancer risk and mortality. Through a better understanding of both how and why prostate cancer epidemiology varies so greatly, we will gain deeper insights into the disease’s biology, to the eventual benefit of at-risk men around the world.

479 citations

Journal ArticleDOI
TL;DR: There has been a rising incidence in stone disease throughout the world with a narrowing of the gender gap and more information is needed regarding stone disease in a large portion of the world including Asia and Africa.
Abstract: Nephrolithiasis is a highly prevalent disease worldwide with rates ranging from 7 to 13% in North America, 5-9% in Europe, and 1-5% in Asia. Due to high rates of new and recurrent stones, management of stones is expensive and the disease has a high level of acute and chronic morbidity. The goal of this study is to review the epidemiology of stone disease in order to improve patient care. A review of the literature was conducted through a search on Pubmed®, Medline®, and Google Scholar®. This review was presented and peer-reviewed at the 3rd International Consultation on Stone Disease during the 2014 Societe Internationale d'Urologie Congress in Glasgow. It represents an update of the 2008 consensus document based on expert opinion of the most relevant studies. There has been a rising incidence in stone disease throughout the world with a narrowing of the gender gap. Increased stone prevalence has been attributed to population growth and increases in obesity and diabetes. General dietary recommendations of increased fluid, decreased salt, and moderate intake of protein have not changed. However, specific recommended values have either changed or are more frequently reported. Geography and environment influenced the likelihood of stone disease and more information is needed regarding stone disease in a large portion of the world including Asia and Africa. Randomized controlled studies are lacking but are necessary to improve recommendations regarding diet and fluid intake. Understanding the impact of associated conditions that are rapidly increasing will improve the prevention of stone disease.

442 citations

Performance
Metrics
No. of papers from the Journal in previous years
YearPapers
2023248
2022364
2021711
2020419
2019345
2018274